CEL-SCI CORPORATION Cash and Cash Equivalents, Period Increase (Decrease)
CEL-SCI CORPORATION (CVM) reported Cash and Cash Equivalents, Period Increase (Decrease) of $20.55 million for the 12-month period ending 2021-09-30, per its 10-K filed 2021-12-21.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-12-21
- CEL-SCI CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2021-09-30 was $102.43K.
- CEL-SCI CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2021-06-30 was $29.53M, a 408.47% increase year-over-year.
- CEL-SCI CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2021-03-31 was -$15.43M, a 411.92% decline year-over-year.
- CEL-SCI CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2020-12-31 was $6.35M, a 576.70% increase year-over-year.
- CEL-SCI CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2021 was $20.55M, a 190.92% increase from fiscal 2020.
- CEL-SCI CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2020 was $7.06M.
- CEL-SCI CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$1.87M, a 123.49% decline from fiscal 2018.
- CEL-SCI CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2018 was $7.94M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2021-09-30 | $102.43K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-21 | $29.63M derived: sum of 2 quarters · filed 2021-12-21 | $14.20M derived: sum of 3 quarters · filed 2021-12-21 | $20.55M 10-K · filed 2021-12-21 |
| 2021-06-30 | $29.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $14.10M derived: sum of 2 quarters · filed 2021-08-13 | $20.45M 10-Q · filed 2021-08-13 | $15.82M derived: sum of 4 quarters · filed 2021-12-21 |
| 2021-03-31 | -$15.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-17 | -$9.08M 10-Q · filed 2021-05-17 | -$13.71M derived: sum of 3 quarters · filed 2021-12-21 | -$7.90M derived: sum of 4 quarters · filed 2021-12-21 |
| 2020-12-31 | $6.35M 10-Q · filed 2021-02-12 | $1.72M derived: sum of 2 quarters · filed 2021-12-21 | $7.53M derived: sum of 3 quarters · filed 2021-12-21 | $12.48M derived: sum of 4 quarters · filed 2021-12-21 |
| 2020-09-30 | -$4.63M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-21 | $1.18M derived: sum of 2 quarters · filed 2021-12-21 | $6.13M derived: sum of 3 quarters · filed 2021-12-21 | $7.06M 10-K · filed 2021-12-21 |
| 2020-06-30 | $5.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $10.75M derived: sum of 2 quarters · filed 2021-08-13 | $11.69M 10-Q · filed 2021-08-13 | $10.65M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $4.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-17 | $5.89M 10-Q · filed 2021-05-17 | $4.84M derived: sum of 3 quarters · filed 2021-05-17 | $8.82M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $938.60K 10-Q · filed 2021-02-12 | -$102.12K derived: sum of 2 quarters · filed 2021-02-12 | $3.87M derived: sum of 3 quarters · filed 2021-02-12 | $2.70M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-09-30 | -$1.04M derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-12-29 | $2.93M derived: sum of 2 quarters · filed 2020-12-31 | $1.76M derived: sum of 3 quarters · filed 2020-12-31 | -$1.87M 10-K · filed 2020-12-29 |
| 2019-06-30 | $3.97M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2020-12-31 | $2.80M derived: sum of 2 quarters · filed 2020-12-31 | -$824.55K 10-Q/A · filed 2020-12-31 | $7.14M derived: sum of 4 quarters · filed 2020-12-31 |
| 2019-03-31 | -$1.17M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2020-12-30 | -$4.80M 10-Q/A · filed 2020-12-30 | $3.17M derived: sum of 3 quarters · filed 2020-12-30 | $2.45M derived: sum of 4 quarters · filed 2020-12-30 |
| 2018-12-31 | -$3.63M 10-Q/A · filed 2020-12-30 | $4.34M derived: sum of 2 quarters · filed 2020-12-30 | $3.62M derived: sum of 3 quarters · filed 2020-12-30 | $4.54M derived: sum of 4 quarters · filed 2020-12-30 |
| 2018-09-30 | $7.96M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-23 | $7.25M derived: sum of 2 quarters · filed 2019-12-23 | $8.17M derived: sum of 3 quarters · filed 2019-12-23 | $7.94M 10-K/A · filed 2019-12-23 |
| 2018-06-30 | -$715.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | $203.92K derived: sum of 2 quarters · filed 2019-08-14 | -$22.79K 10-Q · filed 2019-08-14 | $1.11M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $919.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | $692.75K 10-Q · filed 2019-05-14 | $1.83M derived: sum of 3 quarters · filed 2019-05-14 | $1.53M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | -$226.70K 10-Q · filed 2019-02-14 | $910.26K derived: sum of 2 quarters · filed 2019-02-14 | $612.93K derived: sum of 3 quarters · filed 2019-02-14 | -$243.94K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-09-30 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-19 | $839.64K derived: sum of 2 quarters · filed 2018-12-19 | -$17.23K derived: sum of 3 quarters · filed 2018-12-19 | -$548.56K 10-K · filed 2018-12-19 |
| 2017-06-30 | -$297.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | -$1.15M derived: sum of 2 quarters · filed 2018-08-14 | -$1.69M 10-Q · filed 2018-08-14 | -$3.99M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | -$856.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | -$1.39M 10-Q · filed 2018-05-15 | -$3.69M derived: sum of 3 quarters · filed 2018-05-15 | -$4.52M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$531.32K 10-Q · filed 2018-02-12 | -$2.83M derived: sum of 2 quarters · filed 2018-02-12 | -$3.67M derived: sum of 3 quarters · filed 2018-02-12 | -$8.04M derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-09-30 | -$2.30M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-12-29 | -$3.13M derived: sum of 2 quarters · filed 2017-12-29 | -$7.50M derived: sum of 3 quarters · filed 2017-12-29 | -$2.81M 10-K · filed 2017-12-29 |
| 2016-06-30 | -$833.13K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-12-11 | -$5.20M derived: sum of 2 quarters · filed 2017-12-11 | -$507.72K 10-Q/A · filed 2017-12-11 | -$6.01M derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | -$4.37M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-12-11 | $325.41K 10-Q/A · filed 2017-12-11 | -$5.18M derived: sum of 3 quarters · filed 2017-12-11 | $3.44M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-12-31 | $4.70M 10-Q/A · filed 2017-12-11 | -$808.18K derived: sum of 2 quarters · filed 2017-12-11 | $7.81M derived: sum of 3 quarters · filed 2017-12-11 | $961.02K derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | -$5.50M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $3.11M derived: sum of 2 quarters · filed 2017-12-11 | -$3.73M derived: sum of 3 quarters · filed 2017-12-11 | -$2.79M 10-K/A · filed 2017-12-11 |
| 2015-06-30 | $8.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $1.77M derived: sum of 2 quarters · filed 2016-08-09 | $2.72M 10-Q · filed 2016-08-09 | -$3.06M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-03-31 | -$6.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | -$5.90M 10-Q · filed 2016-05-10 | -$11.67M derived: sum of 3 quarters · filed 2017-12-11 | -$7.99M derived: sum of 4 quarters · filed 2017-12-11 |
| 2014-12-31 | $947.62K 10-Q · filed 2016-02-09 | -$4.82M derived: sum of 2 quarters · filed 2017-12-11 | -$1.14M derived: sum of 3 quarters · filed 2017-12-11 | -$4.03M derived: sum of 4 quarters · filed 2017-12-11 |
| 2014-09-30 | -$5.77M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | -$2.09M derived: sum of 2 quarters · filed 2017-12-11 | -$4.98M derived: sum of 3 quarters · filed 2017-12-11 | $8.47M 10-K/A · filed 2017-12-11 |
| 2014-06-30 | $3.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-07 | $791.68K derived: sum of 2 quarters · filed 2015-08-07 | $14.24M 10-Q · filed 2015-08-07 | $10.80M derived: sum of 4 quarters · filed 2015-12-11 |
| 2014-03-31 | -$2.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | $10.56M 10-Q · filed 2015-05-08 | $7.12M derived: sum of 3 quarters · filed 2015-12-11 | $3.62M derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-12-31 | $13.45M 10-Q · filed 2015-02-06 | $10.01M derived: sum of 2 quarters · filed 2015-12-11 | $6.51M derived: sum of 3 quarters · filed 2015-12-11 | $2.76M derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-09-30 | -$3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | -$6.94M derived: sum of 2 quarters · filed 2015-12-11 | -$10.69M derived: sum of 3 quarters · filed 2015-12-11 | -$3.90M 10-K · filed 2015-12-11 |
| 2013-06-30 | -$3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-08 | -$7.25M derived: sum of 2 quarters · filed 2014-08-08 | -$456.97K 10-Q · filed 2014-08-08 | -$3.74M derived: sum of 4 quarters · filed 2014-12-23 |
| 2013-03-31 | -$3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | $3.04M 10-Q · filed 2014-05-12 | -$236.38K derived: sum of 3 quarters · filed 2014-12-23 | $1.72M derived: sum of 4 quarters · filed 2014-12-23 |
| 2012-12-31 | $6.80M 10-Q · filed 2014-02-10 | $3.51M derived: sum of 2 quarters · filed 2014-12-23 | $5.47M derived: sum of 3 quarters · filed 2014-12-23 | $7.27M derived: sum of 4 quarters · filed 2014-12-23 |
| 2012-09-30 | -$3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-23 | -$1.33M derived: sum of 2 quarters · filed 2014-12-23 | $478.81K derived: sum of 3 quarters · filed 2014-12-23 | -$319.55K 10-K · filed 2014-12-23 |
| 2012-06-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-09 | $3.76M derived: sum of 2 quarters · filed 2013-08-09 | $2.96M 10-Q · filed 2013-08-09 | -$3.35M derived: sum of 4 quarters · filed 2013-12-27 |
| 2012-03-31 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-10 | $1.01M 10-Q · filed 2013-05-10 | -$5.31M derived: sum of 3 quarters · filed 2013-12-27 | -$12.47M derived: sum of 4 quarters · filed 2013-12-27 |
| 2011-12-31 | -$798.37K 10-Q · filed 2013-02-08 | -$7.11M derived: sum of 2 quarters · filed 2013-12-27 | -$14.28M derived: sum of 3 quarters · filed 2013-12-27 | -$17.39M derived: sum of 4 quarters · filed 2013-12-27 |
| 2011-09-30 | -$6.32M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | -$13.48M derived: sum of 2 quarters · filed 2013-12-27 | -$16.59M derived: sum of 3 quarters · filed 2013-12-27 | -$22.31M 10-K · filed 2013-12-27 |
| 2011-06-30 | -$7.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-09 | -$10.28M derived: sum of 2 quarters · filed 2012-08-09 | -$15.99M 10-Q · filed 2012-08-09 | -$19.90M derived: sum of 4 quarters · filed 2012-12-14 |
| 2011-03-31 | -$3.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-10 | -$8.83M 10-Q · filed 2012-05-10 | -$12.73M derived: sum of 3 quarters · filed 2012-12-14 | |
| 2010-12-31 | -$5.71M 10-Q · filed 2012-02-09 | -$9.62M derived: sum of 2 quarters · filed 2012-12-14 | ||
| 2010-09-30 | -$3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-14 | -$7.00M 10-K · filed 2012-12-14 | ||
| 2010-06-30 | -$3.09M 10-Q · filed 2011-08-09 | |||
| 2009-09-30 | $32.86M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |